Structures of two coronavirus main proteases: Implications for substrate binding and antiviral drug design

被引:326
作者
Xue, Xiaoyu [1 ,2 ]
Yu, Hongwei [3 ]
Yang, Haitao [1 ,2 ]
Xue, Fei [1 ,2 ]
Wu, Zhixin [3 ]
Shen, Wei [1 ,2 ]
Li, Jun [1 ,2 ]
Zhou, Zhe [1 ]
Ding, Yi [1 ]
Zhao, Qi [1 ,2 ]
Zhang, Xuejun C. [2 ]
Liao, Ming [3 ]
Bartlam, Mark [1 ,2 ,4 ]
Rao, Zihe [1 ,2 ,4 ]
机构
[1] Tsinghua Univ, Struct Biol Lab, Tsinghua Nankai IBP Joint Res Grp Struct Biol, Beijing 100084, Peoples R China
[2] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China
[3] S China Agr Univ, Coll Vet Med, Lab Avian Med, Guangzhou 510642, Guangdong, Peoples R China
[4] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China
关键词
D O I
10.1128/JVI.02114-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Coronaviruses (CoVs) can infect humans and multiple species of animals, causing a wide spectrum of diseases. The coronavirus main protease (M-Pro), which plays a pivotal role in viral gene expression and replication through the proteolytic processing of replicase polyproteins, is an attractive target for anti-CoV drug design. In this study, the crystal structures of infectious bronchitis virus (IBV) M-Pro and a severe acute respiratory syndrome CoV (SARS-CoV) M-Pro mutant (H41A), in complex with an N-terminal autocleavage substrate, were individually determined to elucidate the structural flexibility and substrate binding of M-Pro. A monomeric form of IBV M-Pro was identified for the first time in COV M-Pro, structures. A comparison of these two structures to other available M-Pro structures provides new insights for the design of substrate-based inhibitors targeting CoV M-Pro. Furthermore, a Michael acceptor inhibitor (named N3) was cocrystallized with IBV M-Pro and was found to demonstrate in vitro inactivation of IBV M-Pro and potent antiviral activity against IBV in chicken embryos. This provides a feasible animal model for designing wide-spectrum inhibitors against CoV-associated diseases. The structure-based optimization of N3 has yielded two more efficacious lead compounds, N27 and H16, with potent inhibition against SARS-CoV M-Pro.
引用
收藏
页码:2515 / 2527
页数:13
相关论文
共 37 条
[21]   Refinement of macromolecular structures by the maximum-likelihood method [J].
Murshudov, GN ;
Vagin, AA ;
Dodson, EJ .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 1997, 53 :240-255
[22]   THE 3-DIMENSIONAL STRUCTURE OF RETINOL-BINDING PROTEIN [J].
NEWCOMER, ME ;
JONES, TA ;
AQVIST, J ;
SUNDELIN, J ;
ERIKSSON, U ;
RASK, L ;
PETERSON, PA .
EMBO JOURNAL, 1984, 3 (07) :1451-1454
[23]   Processing of X-ray diffraction data collected in oscillation mode [J].
Otwinowski, Z ;
Minor, W .
MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 :307-326
[24]   Coronavirus as a possible cause of severe acute respiratory syndrome [J].
Peiris, JSM ;
Lai, ST ;
Poon, LLM ;
Guan, Y ;
Yam, LYC ;
Lim, W ;
Nicholls, J ;
Yee, WKS ;
Yan, WW ;
Cheung, MT ;
Cheng, VCC ;
Chan, KH ;
Tsang, DNC ;
Yung, RWH ;
Ng, TK ;
Yuen, KY .
LANCET, 2003, 361 (9366) :1319-1325
[25]  
Pereira HG, 1989, ANDREWES VIRUSES VER, P42
[26]  
REED L. J., 1938, AMER JOUR HYG, V27, P493
[27]   Substructure solution with SHELXD [J].
Schneider, TR ;
Sheldrick, GM .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 :1772-1779
[28]   Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme - Defining the extra domain as a new target for design of highly specific protease inhibitors [J].
Shi, JH ;
Wei, Z ;
Song, JX .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (23) :24765-24773
[29]  
Snijder E. J., 1995, The coronaviridae., P239
[30]  
Spaan W. J. M., 2004, VIRUS TAXONOMY, P945